“What I recommend for most of my patients who have significant COPD is to enroll in a pulmonary rehabilitation program .” ...

A recent study has shown that simple home-based exercises can significantly reduce hospitalizations for patients with Chronic ...

Lung disease symptoms may make you afraid to exercise, but it’s actually good for your lungs, says Frank C. Sciurba, MD, director of the Emphysema/COPD Research Center at the University of ...

Second Phase 3 Clinical Trial Again Shows Dupilumab Lessens Disease in COPD Patients With Type 2 Inflammation May 20, 2024 — Chronic obstructive pulmonary disease patients with type 2 ...

More research is necessary on the modifiable predictors of a sedentary lifestyle in COPD patients. Structured exercise programs and pulmonary rehabilitation have shown important results for ...

For people in the MetroWest region living with lung diseases such as chronic obstructive pulmonary disease (COPD), emphysema, ...

Distinct patterns of symptom severity among patients with COPD sheds light on the heterogeneous nature of the patients’ ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD exacerbations in some patients whose symptoms aren’t adequately controlled with inhaled medicines.

It is clinically relevant among patients with COPD and may lead to dyspnea, impaired exercise tolerance, increased hospitalizations, respiratory failure, and increased mortality. Hyperinflation in ...

The following is a summary of "Determining the Impact of COVID-19 Infection on Patients Hospitalized With COPD Exacerbations: ...

Findings showed a statistically significant and clinically meaningful reduction in the annualized rate of moderate to severe exacerbations with mepolizumab vs placebo. Mepolizumab was found to ...

Background Clinical studies have shown that glucagon-like peptide-1 receptor agonists (GLP-1 RA) can have beneficial effects ...